Skip to main content

Orchid Cellmark Extends UK Scrapie Genotyping Contract; Deal Worth More than $7M

NEW YORK (GenomeWeb News) - Orchid Cellmark today said it has renewed an ongoing contract with the United Kingdom to continue offering genotyping services to sheep farmers in an effort to combat scrapie.
 
The company reported that the contract, awarded under the National Scrapie Plan for Great Britain, is worth more than $3.5 million per year.
 
The UK government extended the contract through 2007 and 2008, Orchid said.
 
Orchid will use its DNA testing services to help sheep farmers breed sheep that are less genetically susceptible to the disease. The UK plan hopes to use genetic analysis to completely eradicate the disease.
 
Scrapie, a spongiform encephalopathy named for one of its symptoms (sheep with scrapie tend to scrape their fleece against rocks and fences), causes significant losses to farmers around the world annually.

The Scan

And For Adolescents

The US Food and Drug Administration has authorized the Pfizer-BioNTech SARS-CoV-2 vaccine for children between the ages of 12 and 15 years old.

Also of Concern to WHO

The Wall Street Journal reports that the World Health Organization has classified the SARS-CoV-2 variant B.1.617 as a "variant of concern."

Test for Them All

The New York Times reports on the development of combined tests for SARS-CoV-2 and other viruses like influenza.

PNAS Papers on Oral Microbiome Evolution, Snake Toxins, Transcription Factor Binding

In PNAS this week: evolution of oral microbiomes among hominids, comparative genomic analysis of snake toxins, and more.